SM
Susan E Morano (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in Boston Scientific Corporation (BSX). Across 1 priced purchase filing, the average 21-session return was -8.5% from execution and -4.9% from disclosure (delay-adjusted; derived). The largest single filing was $100K of BSX (2,040 sh × $49.22, as filed), executed Aug 25. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
-8.5%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
-4.9%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
1d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$100K
shares × price, as filed
Last traded
Aug 25
Filed Aug 26
Median ADV $938.4M across their filed names
Open performance→Volume by month
Buys $100K
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
BSXRecent filings
BSXPURCHASE
Boston Scientific Corporation
View filing →
$100K2,040 sh × $49.22
Exec Aug 25
Filed Aug 26 · 6:46 PM ET